|Dr. Carel Aron van der Merwe||CEO & Exec. Director||689.4k||N/A||1963|
|Mr. Petrus Jurgens Myburgh||Group CFO & Exec. Director||527k||N/A||1975|
|Dr. Dirk C. Le Roux||Chief Information Officer||N/A||N/A||1960|
|Mr. James Arnold||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Magnus U. Oetiker||Chief HR & Corp. Devel. Officer||N/A||N/A||1972|
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 18 hospitals, 2 day clinics, 3 outpatient clinics, and 112 theatres with approximately 1,916 inpatient beds in Switzerland; 49 hospitals, 8 day clinics, 5 sub-acute hospitals, and 296 theatres in South Africa, as well as 3 hospitals in Namibia with approximately 8,517 inpatient beds; and 7 hospitals, 2 day clinics, 18 outpatient clinics, and 37 theatres with approximately 926 inpatient beds in the United Arab Emirates. The company also provides treasury, hospital equipment, debt collection and related, emergency medical, management, food and catering, procurement, and healthcare management services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. Mediclinic International plc was founded in 1983 and is based in Stellenbosch, South Africa.
Mediclinic International plc’s ISS Governance QualityScore as of October 4, 2019 is 8. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 1; Compensation: 9.